Patient Square Capital LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, Patient Square Capital LP held in its portfolio 28 assets valued at $467,131,666 (i.e. $467.13M).
The most valuable assets in the portfolio included: ROIVANT SCIENCES LTD ($177.20M), INSMED INC ($46.47M), and MIRUM PHARMACEUTICALS INC ($23.59M).
The chart below shows the top 10 valuable assets, and the table below shows the top 28 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Patient Square Capital LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| ROIVANT SCIENCES LTD | 8166047 | 177203220 | SHS |
| INSMED INC | 267000 | 46468680 | COM PAR $.01 |
| MIRUM PHARMACEUTICALS INC | 298682 | 23592891 | COM |
| ARGENX SE | 26000 | 21864700 | SPONSORED ADR |
| BEONE MEDICINES LTD | 69312 | 21057679 | SPONSORED ADS |
| ABIVAX SA | 130000 | 17530500 | SPONSORED ADS |
| PHARVARIS N V | 542696 | 15059814 | COM |
| EYEPOINT INC | 780000 | 14250600 | COM NEW |
| TERNS PHARMACEUTICALS INC | 320000 | 12928000 | COM |
| CELCUITY INC | 120000 | 11968800 | COM |
| COGENT BIOSCIENCES INC | 317372 | 11273053 | COM |
| KYMERA THERAPEUTICS INC | 139000 | 10815590 | COM |
| LIQUIDIA CORPORATION | 227000 | 7829230 | COM NEW |
| DBV TECHNOLOGIES S A | 359050 | 6882989 | SPONSORED ADS |
| ALLOGENE THERAPEUTICS INC | 4963756 | 6800346 | COM |
| DIANTHUS THERAPEUTICS INC | 150000 | 6181500 | COM |
| XENON PHARMACEUTICALS INC | 136500 | 6117930 | COM |
| ARCUTIS BIOTHERAPEUTICS INC | 210000 | 6098400 | COM |
| OCULAR THERAPEUTIX INC | 490000 | 5948600 | COM |
| DISC MEDICINE INC | 74000 | 5876340 | COM |
| AVALO THERAPEUTICS INC | 311966 | 5665303 | COM NEW |
| SPYRE THERAPEUTICS INC | 150000 | 4914000 | COM NEW |
| ENLIVEN THERAPEUTICS INC | 308141 | 4745371 | COM |
| ASSEMBLY BIOSCIENCES INC | 127000 | 4319270 | COM NEW |
| AMYLYX PHARMACEUTICALS INC | 350000 | 4228000 | COM |
| ARCUS BIOSCIENCES INC | 170000 | 4051100 | COM |
| PERSPECTIVE THERAPEUTICS INC | 1132815 | 3115241 | COM NEW |
| HARROW INC | 7031 | 344519 | COM |